Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp (NASDAQ: AHCO) operates as one of the largest home medical equipment and respiratory services providers in the United States, with operations spanning 46 states. As a publicly traded healthcare company, AdaptHealth regularly generates news across several categories that matter to investors and healthcare industry observers tracking the home medical equipment sector.
Earnings announcements represent a significant portion of AdaptHealth news coverage, with quarterly and annual results providing insight into revenue trends across the company's therapeutic segments including sleep therapy, respiratory equipment, mobility products, and wound care supplies. These financial disclosures reveal how the company navigates Medicare reimbursement rates, payor mix changes, and demand patterns for home healthcare equipment.
Partnership and acquisition news frequently emerges from AdaptHealth as the company has built its national presence through strategic growth. Announcements involving health system partnerships, regional acquisitions, or expanded service agreements signal how the company is extending its geographic reach and referral networks. These developments matter because scale provides competitive advantages in an industry with pressure on reimbursement rates.
Investor conference participation and analyst presentations offer windows into management perspectives on industry trends, including the ongoing shift toward home-based care delivery, chronic disease management outside hospitals, and the impact of healthcare policy on durable medical equipment providers. Credit rating changes and debt refinancing activities also generate news given the capital-intensive nature of equipment distribution.
Bookmark this page to follow AdaptHealth developments including earnings releases, strategic transactions, and operational updates relevant to understanding this home healthcare equipment company's trajectory.
AdaptHealth Corp. (NASDAQ: AHCO) has announced significant changes to its board of directors and management. Dale Wolf has been appointed as Chair of the Board of Directors effective July 1, 2024, succeeding Richard Barasch. Dale Wolf has been a board member since November 2019. Additionally, CEO Suzanne Foster has joined the Board effective May 20, 2024. President Josh Parnes will step down from his role on August 31, 2024, and from the Board on December 31, 2024.
AdaptHealth specializes in providing home medical equipment, supplies, and related services, reaching approximately 4.1 million patients across the U.S. annually through its extensive network.
AdaptHealth Corp. (NASDAQ: AHCO) announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024. AdaptHealth, a leader in providing patient-centered, healthcare-at-home solutions, will present at 9:20am ET. The company offers a comprehensive range of medical products and services, including sleep therapy equipment, diabetes treatment devices, home medical equipment, and chronic therapy services. AdaptHealth serves about 4.1 million patients annually through 680 locations in 47 states, partnering with a diverse network of referral sources like hospitals and clinics.
AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, announced its participation in the Jefferies Global Healthcare Conference in New York on June 5, 2024. The event will include a fireside chat at 4:00 pm ET, accessible via webcast on the company's website. AdaptHealth offers a comprehensive range of home medical equipment and services, including sleep therapy, diabetes treatment, and chronic condition management. The company serves around 4.1 million patients annually across all 50 states through a network of 680 locations in 47 states. Further details can be found on their investor relations page.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in the UBS Healthcare Services Cape Cod Summit on June 4, 2024. AdaptHealth provides a range of home medical equipment and services, including sleep therapy, diabetes treatment, and chronic therapy services. The company supports 4.1 million patients annually in all 50 states through a network of 680 locations in 47 states. AdaptHealth partners with a diverse network of referral sources such as hospitals, clinics, and skilled nursing facilities.
AdaptHealth Corp. (NASDAQ: AHCO) announced the grant of restricted stock units (RSUs) to Suzanne Foster, the newly appointed CEO, as an inducement under Nasdaq Listing Rule 5635(c)(4). The grant, approved by the Compensation Committee on May 11, 2024, covers 553,251 shares of common stock at target performance levels. The RSUs vest in three tranches: 229,740 shares over three years starting May 20, 2025, 93,771 shares over two years starting the same date, and the remaining shares based on the Total Shareholder Return (TSR) over a three-year period. The vesting depends on Ms. Foster's continued service with AdaptHealth. The company provides home medical equipment and services, reaching 4.1 million patients annually across 670 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in the 2024 Leerink Partners Healthcare Crossroads Conference in Austin on May 29, 2024, with a fireside chat at 3:00 PM CT. AdaptHealth is a national provider of patient-centered healthcare-at-home solutions, including home medical equipment, supplies, and related services. Their services cater to patients with chronic conditions, offering sleep therapy equipment, diabetes treatment devices, and other home medical equipment. The company reaches approximately 4.1 million patients annually across all 50 states through 680 locations in 47 states. A webcast link for the event will be available on the company's website under 'Investor Relations'.
AdaptHealth Corp. will participate in the BofA Securities 2024 Health Care Conference, with key executives engaging in a fireside chat. The Company offers patient-centered healthcare-at-home solutions, catering to over 4.1 million patients annually in all 50 states. AdaptHealth provides a wide range of medical products and services, including sleep therapy equipment, diabetes treatment supplies, HME devices, oxygen therapy, and other related services.
AdaptHealth Corp. announced financial results for the first quarter ended March 31, 2024. Net revenue increased by 6.4% to $792.5 million. However, net loss was $2.1 million compared to net income of $15.7 million in the same period last year. Adjusted EBITDA increased by 18.3% to $158.5 million. Cash flow from operations decreased to $49.0 million, and Free Cash Flow decreased to $(38.9) million due to delayed payments from the Change Healthcare data breach.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
